| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 浙江圣达生物药业股份有限公司（以下简称公司或本公司）前身系浙江圣达药业有限公司（以下简称圣达药业公司），圣达药业公司于1999年2月8日在天台县工商行政管理局登记注册，取得注册号为331023000003829的企业法人营业执照。圣达药业公司以2013年7月31日为基准日，整体变更为股份有限公司，于2013年12月13日在台州市工商行政管理局登记注册，总部位于浙江省台州市天台县。公司现持有统一社会信用代码为9133100070471153X3的营业执照，注册资本6,000万元，股份总数6,000万股（每股面值1元)。 公司主要从事食品和饲料添加剂的研发、生产及销售，产品主要包括生物素、叶酸等维生素类产品和乳酸链球菌素、纳他霉素等生物保鲜剂。 | ||||||||||||||||||||||||
| Main Business | 维生素、生物保鲜剂、食品添加剂和饲料添加剂的研发、生产和销售。 | ||||||||||||||||||||||||
| Legal Representative | 周斌 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | ZHU JENNY YI - XUAN | ||||||||||||||||||||||||
| Solicitors | 北京市金杜律师事务所 | ||||||||||||||||||||||||
| Auditors | 天健会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0576-83966211;0576-83966111;0576-83938598 | ||||||||||||||||||||||||
| Fax No | 0576-83993731;0576-83966111 | ||||||||||||||||||||||||
| Website | www.sd-pharm.com | ||||||||||||||||||||||||
| zqb@sd-pharm.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 23/08/2017 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -0.320 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.060 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 7.329 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 2.696B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |